Microplastics—tiny fragments of plastic smaller than five millimeters—have been detected throughout the human body, raising questions about their potential health effects and how individuals can assess their personal exposure. Despite widespread awareness that microplastics originate from sources such as bottled water, processed foods, clothing, and household items, scientific understanding of their impact on human health remains in the early stages.
Microplastic testing kits designed for at-home use have emerged in recent years, offering consumers a way to measure the particles circulating in their blood and saliva. One such product, PlasticTox by Arrow Lab Solutions, has made these tests commercially available since 2023. The tests, which cost between $135 and $150, provide a particle count and allow users to compare their results to a database of over 1,000 samples.
To collect blood for the test, users must prick their finger with a lancet and deposit a small sample on a collection card, while the saliva test requires fasting for at least two hours prior to spitting into a vial. Both collection methods can be challenging, with potential for sample contamination—a concern noted by experts in the field. Alan Morrison, CEO of Arrow Lab, emphasized the company's rigorous effort to minimize contamination risks through careful review of each test component.
Results from these tests report the number and size distribution of microplastic particles detected, typically categorized as less than 10 micrometers or between 10 and 30 micrometers. Smaller particles are of particular interest since research suggests they penetrate deeper into body tissues and may pose greater health risks.
Studies have found microplastic particles in diverse organs and fluids, including the lungs, heart, kidneys, liver, brain, ovaries, and eye fluid. Phoebe Stapleton, an associate professor of pharmacology and toxicology at Rutgers University, confirmed the pervasive presence of microplastics in the body. However, researchers caution that these tests currently provide limited insight into how much plastic accumulates over time or the extent to which particles are eliminated naturally.
Experts acknowledge that the user base for such tests likely skews toward health-conscious individuals, making the existing data non-representative of the general population. Dr. Robert Wright, director of environmental medicine at the Icahn School of Medicine at Mount Sinai, pointed out that more comprehensive studies are needed to interpret these findings fully.
While the clinical implications are still unclear, some research has identified associations between microplastic exposure and cardiovascular disease. Dr. Matthew Campen of the University of New Mexico highlighted evidence from human and animal models linking higher microplastic levels with increased heart disease risk. Additional studies in cell cultures and animals suggest potential roles for microplastics in inflammation, oxidative stress, and cancer development.
Given the uncertain health effects, specialists recommend strategies to reduce microplastic exposure. These include minimizing consumption of processed foods, using stainless steel water bottles, running air purifiers, selecting natural fiber clothing, avoiding heating food in plastic containers, and storing food in glass or foil.
As testing technology and research evolve, scientists stress the importance of measuring not only particle quantity and size but also the specific types of plastics and their distribution in the body. Dr. Kara Meister of Stanford University emphasized that a comprehensive understanding of microplastics’ health impact is still forthcoming, noting that current tests primarily establish baseline exposure rather than definitive risk.
For now, individuals can measure their microplastic levels but must navigate the limited interpretive value. The focus remains on mitigating exposure through known environmental controls while researchers continue to explore the broader health implications of this emerging contaminant.